Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» PDL-1 inhibitors
PDL-1 inhibitors
Regeneron’s coming late to a group of drugs that’s already worth billions — here’s why the company thinks it can still compete
SF Gate, CA
Sat, 02/10/18 - 09:47 am
Regeneron
PDL-1 inhibitors
cemiplimab
Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for
Endpoints
Tue, 05/30/17 - 11:48 am
ASCO
IDO inhibitors
CAR-T
PDL-1 inhibitors
Merck
Incyte
NewLink Genetics
Novartis
Juno Therapeutics
Bristol-Myers Squibb
Bristol-Myers takes a commanding lead over Merck in the first stretch of a blockbuster race
Endpoints
Fri, 07/29/16 - 08:44 pm
Bristol-Myers Squibb
Merck
Keytruda
Opdivo
PDL-1 inhibitors
Epizyme partners with Roche to test cancer drug combo
BioPharma Dive
Thu, 06/23/16 - 08:22 pm
Epizyme
Roche
PDL-1 inhibitors
diffuse large B-cell lymphoma
Tecentriq
tazemetostat
Five Storylines To Watch At ASCO
Forbes
Tue, 05/31/16 - 11:14 am
ASCO 2016
drug pricing
Pfizer
Ibrance
breast cancer
Tecentriq
Genentech
Roche
PDL-1 inhibitors
AstraZeneca hit with setback as durvalumab falls further behind on lung cancer
Fierce Biotech
Sat, 12/19/15 - 11:28 am
AstraZeneca
durvalumab
PDL-1 inhibitors
lung cancer
Keytruda's label confers edge for Opdivo
Medical Marketing and Media
Mon, 10/5/15 - 06:02 pm
Keytruda
Opdivo
Merck
Bristol-Myers Squibb
PDL-1 inhibitors
The Biggest Selling Cancer Drugs In 2020 Show Significant Change Expected In Five Short Years
Forbes
Mon, 06/1/15 - 11:34 pm
ASCO
PDL-1 inhibitors
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
A preview of the new lung cancer data Roche will debut at ASCO
BioPharma Dive
Fri, 05/15/15 - 09:34 am
non-small cell lung cancer
ASCO
Roche
Genentech
MPDL3280A
PDL-1 inhibitors
Novartis grabs Zykadia approval in Europe, setting the stage for PD-L1 showdown
Fierce Pharma
Fri, 05/8/15 - 04:38 pm
Novartis
Zykadia
Europe
Pfizer
Xalkori
PDL-1 inhibitors
Merck's Keytruda shrinks lung cancer tumors, FDA approval sought
Yahoo/Reuters
Sun, 04/19/15 - 12:02 pm
Merck
Keytruda
lung cancer
FDA
non-small cell lung cancer
PDL-1 inhibitors
New cancer drugs "vastly overestimated", says contrarian analyst
Yahoo/Reuters
Tue, 03/31/15 - 12:46 pm
cancer
PD-1 inhibitors
PDL-1 inhibitors
Opdivo
Keytruda
Merck
Bristol-Myers Squibb